Article citationsMore>>

Sebastian, M., et al. (2019) A Phase I/IIa Study of the mRNA-Based Cancer Immunotherapy CV9201 in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer. Cancer Immunology, Immunotherapy, 68, 799-812.
https://doi.org/10.1007/s00262-019-02315-x

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top